Abstract
Objective Bipolar disorder (BD) often presents with a broad range of symptoms, but there is little agreement as to the heritability and genetic relationships between dimensional and categorical models of this often-disabling disorder.
Methods Participants in the Amish-Mennonite Bipolar Genetics (AMBiGen) study, which enrolls families with BD and related disorders from Amish and Mennonite communities in North and South America, were assigned a categorical mood disorder diagnosis by structured psychiatric interview and asked to complete the Mood Disorder Questionnaire (MDQ), which assesses lifetime history of cardinal manic symptoms and associated impairment. Principal Component Analysis (PCA) was performed to analyze the dimensions of the MDQ in 726 participants, 212 of whom carried a categorical diagnosis of major mood disorder. SOLAR-ECLIPSE (v9.0.0) was used to estimate heritability and genetic overlaps between MDQ-derived measures and categorical diagnoses among 432 genotyped participants.
Results As expected, MDQ scores were significantly higher among individuals diagnosed with BD and related disorders. PCA suggested a three-component model for the MDQ, consistent with the literature. Heritability of the MDQ symptom score was estimated at 30% (p<0.001), which was evenly distributed across its three principal components. Strong and significant genetic correlations were found between categorical diagnoses and most MDQ measures, especially impairment.
Conclusion The results support the MDQ as a dimensional measure of BD. Furthermore, significant heritability and high genetic correlations between MDQ scores and categorical diagnoses suggest a genetic continuity between dimensional and categorical measures of major mood disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by the Intramural Research Program of the National Institute of Mental Health (NIMH), ZIA MH002843.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of the National Institute of Mental Health gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Fixed abstract and spelling/grammar errors.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
